A report by the Wall Street Journal, indicating that Merck & Co. and Allergan Plc have each considered a takeover of Biogen Inc., set shares of the biotech company off on Tuesday. Biogen shares climbed 9.4 percent to $330.11 at the close in New York. This was their biggest one-day gain since March of last … Continue reading “Biogen (BIIB) Shares Explode After WallStreet Report”
